We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BVS icon
126
Bioventus
BVS
$910M
$1.57M 0.2%
165,865
+42,813
+35% +$409K
2024 Q3
7 quarters
GCT icon
127
GigaCloud Technology
GCT
$2.08B
$1.56M 0.2%
49,411
– –
2025 Q2
4 quarters
NTAP icon
128
NetApp
NTAP
$39.1B
$1.56M 0.2%
10,056
– –
2020 Q4
22 quarters
PINE icon
129
Alpine Income Property Trust
PINE
$294M
$1.54M 0.2%
73,955
– –
2024 Q2
8 quarters
CERS icon
130
Cerus
CERS
$459M
$1.52M 0.19%
522,099
– –
2025 Q4
2 quarters
ELMD icon
131
Electromed
ELMD
$224M
$1.5M 0.19%
35,470
+341
+1% +$10.9K
2020 Q2
24 quarters
MTZ icon
132
MasTec
MTZ
$14.9B
$1.49M 0.19%
3,574
+609
+21% +$233K
2024 Q4
6 quarters
IRMD icon
133
iRadimed
IRMD
$981M
$1.49M 0.19%
15,546
– –
2024 Q3
7 quarters
FSS icon
134
Federal Signal
FSS
$6.87B
$1.46M 0.19%
11,378
+9,174
+416% +$1.05M
2021 Q4
18 quarters
HLIT icon
135
Harmonic Inc
HLIT
$1.12B
$1.46M 0.19%
89,368
+4,394
+5% +$56.1K
2025 Q4
2 quarters
PHIN icon
136
Phinia Inc
PHIN
$2.26B
$1.43M 0.18%
17,366
+199
+1% +$15.2K
2026 Q1
1 quarter
RM icon
137
Regional Management Corp
RM
$333M
$1.43M 0.18%
34,663
– –
2020 Q1
25 quarters
CBL icon
138
CBL Properties
CBL
$1.56B
$1.43M 0.18%
+26,886
New +$1.24M
2026 Q2
0 quarters
SKWD icon
139
Skyward Specialty Insurance
SKWD
$2.62B
$1.4M 0.18%
23,925
– –
2024 Q2
8 quarters
GCMG icon
140
GCM Grosvenor
GCMG
$773M
$1.39M 0.18%
112,982
-9,301
-8% -$102K
2026 Q1
1 quarter
PENG icon
141
Penguin Solutions Inc
PENG
$2.66B
$1.38M 0.18%
+18,100
New +$823K
2026 Q2
0 quarters
NWPX icon
142
NWPX Infrastructure Inc
NWPX
$942M
$1.37M 0.17%
9,128
+7,071
+344% +$774K
2026 Q1
1 quarter
ANGO icon
143
AngioDynamics
ANGO
$504M
$1.36M 0.17%
104,155
– –
2024 Q3
7 quarters
CARS icon
144
Cars.com
CARS
$602M
$1.34M 0.17%
122,940
– –
2021 Q2
20 quarters
TLS icon
145
Telos
TLS
$405M
$1.34M 0.17%
+290,386
New +$1.28M
2026 Q2
0 quarters
DSP icon
146
Viant Technology
DSP
$272M
$1.32M 0.17%
103,977
– –
2023 Q3
11 quarters
CXM icon
147
Sprinklr
CXM
$1.58B
$1.31M 0.17%
253,891
– –
2025 Q4
2 quarters
CRC icon
148
California Resources
CRC
$4.93B
$1.3M 0.17%
+24,519
New +$1.51M
2026 Q2
0 quarters
CAH icon
149
Cardinal Health
CAH
$58B
$1.29M 0.16%
5,420
– –
2019 Q4
26 quarters
ANIK icon
150
Anika Therapeutics
ANIK
$280M
$1.28M 0.16%
87,600
– –
2023 Q4
10 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.